Selection of mutant CHO clones resistant to murine gammaherpesvirus 68 infection

Virology
Nadine Jarousse, Laurent Coscoy

Abstract

Murine gammaherpesvirus 68 (MHV68) is used as a model to study gammaherpesvirus pathogenesis both in tissue culture systems and in vivo. We used a gene-trapping approach to get insight into cellular factors involved in MHV68 infection. By generating a library of gene-trapped CHO cells, we were able to isolate several clones that exhibited various degrees of resistance to MHV68-induced cytopathic effect. Clones that showed the highest degree of resistance were affected at the early stage of the viral cycle, with the vast majority of these clones being deficient for heparan sulfate (HS) expression at the cell surface. Heparan sulfate expression could be restored in all the HS-deficient clones by expression of EXT1, an enzyme that is essential for the biosynthesis of HS. Consistent with the role of HS in viral entry, HS-deficient CHO cells did not support viral internalization. Cell surface heparan sulfate proteoglycans (HSPG) are mostly composed of HS chains attached to two families of core proteins, the transmembrane syndecans and the GPI-anchored glypicans. Treatment of CHO cells with phosphatidylinositol-specific phospholipase C (PI-PLC) did not significantly affect the level of HS expression, indicating that the glypicans are...Continue Reading

References

Dec 1, 1992·The Journal of General Virology·N P Sunil-ChandraA A Nash
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J M AhearnD T Fearon
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·J SpringM Bernfield
Jun 6, 1997·The Journal of Biological Chemistry·S V SubramanianM Bernfield
Aug 1, 1997·Journal of Virology·H W VirginS H Speck
Oct 23, 1997·Current Opinion in Lipidology·K J Williams, I V Fuki
Jun 24, 1998·The Journal of Experimental Medicine·J P StewartT Nash
Aug 26, 1998·Trends in Microbiology·J P Simas, S Efstathiou
Dec 11, 1999·Proceedings of the Association of American Physicians·J S Pagano
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·C McCormickF Tufaro
Jun 29, 2000·Annual Review of Biochemistry·M BernfieldM Zako
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·E FlañoM A Blackman
Jul 14, 2000·AIDS·D J BlackbournJ A Levy
Jun 1, 2001·Nature Biotechnology·E MedicoP Soriano
Jul 18, 2001·The Journal of Clinical Investigation·R V Iozzo
Aug 24, 2001·The Journal of Clinical Investigation·D Shukla, P G Spear
Oct 5, 2001·Nature Reviews. Genetics·W L StanfordS P Cordes
Dec 18, 2001·Medicinal Research Reviews·Jian Liu, Suzanne C Thorp

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.